UK regulators approve injectable form of nivolumab for solid tumours
The Medicines and Healthcare products Regulatory Agency (MHRA) in the [...]
Immunotherapy for the treatment of non-clear cell kidney cancer
There are several types of kidney cancer, the most common [...]
IKCC Global Kidney Cancer Summit
Julia Black, Karen McNee and Steve Pointon represented UK kidney [...]
Europe has approved subcutaneous nivolumab for solid tumours
The Committee for Medicinal Products for Human Use (CHMP) of [...]
The Big Cancer52 Conversation
Earlier this week, Sharon Deveson Kell represented kidney cancer patients [...]
A urine test to detect the return of kidney cancer
A study has shown that a simple urine test could [...]
Spotting symptoms early: the importance of early diagnosis
Cancer Research UK have been highlighting the importance of screening [...]
Health-related quality of life with belzutifan versus everolimus for advanced kidney cancer
People with kidney cancer have been shown to have changes (mutations) in [...]
Combinations of pembrolizumab and targeted therapies for advanced clear cell kidney cancer
The KEYMAKER-U03 study is looking at different combinations of immunotherapy [...]
Safe Sick Pay Campaign Update
For months we’ve been campaigning with workers, The Centre for [...]
